Psoriasis: Targets and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.4 | Q2 | 75.8% | — | — | |
| 2024 | 5.7 | Q1 | 93.8% | — | — | |
| 2023 | 5.2 | Q1 | 88.7% | — | — | |
| 2022 | 2.9 | 68.1% | — | — | ||
| 2021 | — | 32.4% | — | — | ||
| 2020 | — | — | 1.066 | Q1 | 86.7% | |
| 2019 | — | — | 1.324 | Q1 | 90.8% | |
| 2018 | — | — | 0.240 | Q3 | 42.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2230-326X
country
NZ